Phillipe Deschamps of Helius Medical Technologies, Inc. (NASDAQ: HSDT), returns to Stock Day to discuss their PoNS technology and therapy platform, working with Health Canada, and possible timeline for receiving FDA results.

Canada # healthcare # Helius Medical Technologies Inc. # HSDT # medical # PONS # service # targeted therapy # tech # therapy # Treatment # US # Montreal